Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2003
04/23/2003EP1304113A1 Isolated stromal cells and methods of using the same
04/23/2003EP1304112A1 Isolated stromal cells and methods of using the same
04/23/2003EP1303625A2 Alpha-msh related compounds and methods of use
04/23/2003EP1303623A2 Pheylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
04/23/2003EP1303620A2 Regulation of human desc1-like serine protease
04/23/2003EP1303619A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction
04/23/2003EP1303610A2 Extracellular matrix protein
04/23/2003EP1303609A2 G-protein coupled receptors
04/23/2003EP1303608A2 Zinc finger domain recognition code and uses thereof
04/23/2003EP1303607A2 High affinity soluble interleukin-18 receptor
04/23/2003EP1303604A2 Mammalian receptor proteins; related reagents and methods
04/23/2003EP1303603A2 G protein-coupled receptor con-218
04/23/2003EP1303602A2 Soluble zalpha11 cytokine receptors
04/23/2003EP1303601A2 G protein-coupled receptors
04/23/2003EP1303600A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
04/23/2003EP1303599A2 Methylated nucleotide regulation of upa gene expression
04/23/2003EP1303596A2 Antisense enzyme inhibitors for improving pharmacokinetics of a drug
04/23/2003EP1303594A2 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b
04/23/2003EP1303592A1 Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same
04/23/2003EP1303591A2 Masp-2, a complement-fixing enzyme, and uses for it
04/23/2003EP1303588A2 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue
04/23/2003EP1303538A2 Ghrelin antagonists
04/23/2003EP1303536A1 Novel fibroblast growth factor (fgf23) and methods for use
04/23/2003EP1303535A2 Protein complex serving as a vehicle for orally administerable medicaments
04/23/2003EP1303534A2 Promyostatin peptides and methods of using same
04/23/2003EP1303492A2 Aza-bridged-bicyclic amino acid derivatives as alpha 4 integrin antagonists
04/23/2003EP1303491A1 Thrombin inhibitors comprising an aminoisoquinoline group
04/23/2003EP1303487A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
04/23/2003EP1303310A1 USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS
04/23/2003EP1303301A2 Preventing airway mucus production by administration of egf-r antagonists
04/23/2003EP1303297A2 Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency
04/23/2003EP1303296A1 Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof
04/23/2003EP1303295A1 Agent for inhibiting adhesion of the pathogenic flora of the skin
04/23/2003EP1303294A2 Method for treating unstable angina pectoris
04/23/2003EP1303293A2 Apo-2l receptor agonist and cpt-11 synergism
04/23/2003EP1303292A1 Chemokine conjugates
04/23/2003EP1303291A1 Anti-hiv and anti-tumor peptides and fragments of lysozyme
04/23/2003EP1303290A1 Small peptides and methods for downregulation of ige
04/23/2003EP1303289A2 Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
04/23/2003EP1303288A1 Mannan-binding lectin (mbl) treatment of infections in individuals treated with tnf-alfa inhibitors
04/23/2003EP1303287A1 Mhc peptides over-expressed on prostate cancer cells and methods of use
04/23/2003EP1303284A1 Compositions and methods for the treatment of skin damage
04/23/2003EP1303260A2 Linkage of agents using microparticles
04/23/2003EP1303259A1 Prolonged release microspheres for injection delivery and preparation method
04/23/2003EP1303186A2 Medicinal uses of mu-opioid receptor agonists
04/23/2003EP1303183A1 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs
04/23/2003EP1250055A4 Immune modulation with death receptor-induced apoptosis
04/23/2003EP1235842A4 Rna interference pathway genes as tools for targeted genetic interference
04/23/2003EP1178820A4 Methods of modulating fabh activity
04/23/2003EP1117681B1 Rho-cocotoxin peptides having selective alpha-1 adrenoceptor activity
04/23/2003EP1098966A4 Methods for purifying nucleic acids
04/23/2003EP1082314B1 New dipeptidyl peptidase iv effectors
04/23/2003EP1028738B1 Use of cytokines and mitogens to inhibit pathological immune responses
04/23/2003EP1019503A4 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides
04/23/2003EP1016714B1 Novel plasmid dna containing reporter gene dna and use of the same
04/23/2003EP0996409B1 Composition for delaying hair growth and corresponding use
04/23/2003EP0906571B1 Labelling and selection of molecules
04/23/2003EP0873134B1 Aqueous prolonged release formulation comprising bovine growth hormone-releasing factor
04/23/2003EP0871654B1 Protegrins
04/23/2003EP0863762A4 Methods of production and use of liquid formulations of plasma proteins
04/23/2003EP0861266B1 Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them
04/23/2003EP0840618B1 Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies
04/23/2003EP0836615B1 New thrombin inhibitors, their preparation and use
04/23/2003EP0817858B1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
04/23/2003EP0764021B1 Uterine fibroid treatment
04/23/2003EP0714439B1 Recombinant humanized anti-human immunodeficiency virus antibody
04/23/2003EP0672145B1 Interleukin-3 (il-3) multiple mutation polypeptides
04/23/2003EP0669978B1 Flk-1 is a receptor for vascular endothelial growth factor
04/23/2003EP0612348B1 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
04/23/2003EP0546124B2 Multidomain hematopoiesis stimulators
04/23/2003EP0483249B1 Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators
04/23/2003CN1413258A Invasive bacterial vectors for expressing alphavirus replicons
04/23/2003CN1413251A Novel endoplasmic reticulum-localized protein, remedies containing the same for diseases associated with glycoprotein abnormality, DNA encoding this protein and gene remedies containing the same
04/23/2003CN1413249A Human heparanase-related polypeptide and nucleic acid
04/23/2003CN1413230A Highly-neutralized ethylene copolymers and their use in golf balls
04/23/2003CN1413210A Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
04/23/2003CN1413125A Sensitive substance encapsulation
04/23/2003CN1413118A Liquid composition of biodegradable block copolymer for drug delivery system and process for preparation thereof
04/23/2003CN1412313A Expression of recombinant human troponin I in colibacillus and its application for resisting tumor
04/23/2003CN1412312A Expression of recombinant human quick skeletal muscle type troponin C in colibacillus and its application for resisting tumor
04/23/2003CN1412295A Oncolytic microorganism expressing heat shock protein and its application
04/23/2003CN1412197A 17 peptide organic compound and its application
04/23/2003CN1411873A Partial chitosan bio-canula capable of inducing and promoting effective regeneration of nerve and its preparation method
04/23/2003CN1106202C Anti-aids immunomodulator complex
04/22/2003US6552246 Marker sequence has been substituted for at least intron 6 and exon 6, and wherein disruption prevents expression of CD45 on B-cells and T-cells and results in a decreased cytotoxic T-cell response
04/22/2003US6552181 Basal cell carcinoma tumor supressor gene
04/22/2003US6552180 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-2 and uses thereof
04/22/2003US6552177 EH domain containing genes and proteins
04/22/2003US6552174 Nucleotide sequences coding preferential polypeptide for use in treatment of cancer
04/22/2003US6552173 Acellular red blood cell substitute
04/22/2003US6552172 Forming water in oil emulsion of fibrinogen, thrombin and factor XIII, homogenizing and isolating
04/22/2003US6552170 Derivatives of polyethylene glycol and related hydrophilic polymers and to polypeptides that have been covalently bonded to such active derivatives
04/22/2003US6552169 Density enhanced protein tyrosine phosphatases
04/22/2003US6552168 Inhibition of apoptosis via attenuation of caspase activity should therefore be useful in the treatment of human diseases where inappropriate apoptosis is prominent or contributes to disease pathogenesis
04/22/2003US6552166 Process for the preparation of conjugates useful in the treatment of prostate cancer
04/22/2003US6552164 Reagents and methods useful for detecting diseases of the breast
04/22/2003US6552045 Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
04/22/2003US6552041 Cyclized amide derivatives useful for treating or preventing neuronal damage associated with neurological disease
04/22/2003US6552038 Anticoagulant agents
04/22/2003US6552016 For inhibiting aberrant growth states resulting from hedgehog gain- of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist, such as a small molecule
1 ... 1862 1863 1864 1865 1866 1867 1868 1869 1870 1871 1872 1873 1874 1875 1876 1877 1878 1879 1880 1881 1882 ... 3163